Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Coloplast A/S Announces Extraordinary Dividend and Confirms FY 2012/2013 Guidance


Tuesday, 30 Apr 2013 05:14am EDT 

Coloplast A/S announced that its Board of Directors has resolved that Coloplast is to pay an extraordinary dividend of DKK 3 per share for a total dividend payout of DKK 634 million. In addition, the Company decided to confirm its guidance for the fiscal year 2012/2013. The Company expects organic revenue growth of between 6% and 7% and growth of between 5% and 6% in DKK, as well as EBIT margin of between 31% and 32%, both at constant exchange rates and in DKK. For the fiscal year 2011/2012, the Company reported revenue of DKK 11,023.00 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report revenue of DKK 11,663.96 million for the fiscal year 2012/2013. 

Company Quote

515.5
5.5 +1.08%
19 Dec 2014